During the past decade, Natalie Warren Bryant Cancer Center at Saint Francis conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 51 clinical trials were completed, i.e. on average, 1275% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 19 clinical trials were completed. i.e. 950% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Natalie Warren Bryant Cancer Center at Saint Francis" #1 sponsor was "National Cancer Institute (NCI)" with 45 trials, followed by "Children's Oncology Group" with 44 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored and "Alliance for Clinical Trials in Oncology" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Natalie Warren Bryant Cancer Center at Saint Francis" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Natalie Warren Bryant Cancer Center at Saint Francis" are "Leukemia" (8 trials), "Sarcoma" (7 trials), "Acute Lymphoblastic Leukemia" (5 trials), "Clear Cell Renal Cell Carcinoma" (5 trials) and "Recurrent Breast Carcinoma" (5 trials). Many other conditions were trialed in "Natalie Warren Bryant Cancer Center at Saint Francis" in a lesser frequency.

Most popular intervention types in "Natalie Warren Bryant Cancer Center at Saint Francis" are "Drug" (84 trials), "Other" (57 trials), "Biological" (44 trials), "Radiation" (34 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (45 trials), "Cyclophosphamide" (15 trials), "Doxorubicin Hydrochloride" (14 trials), "Bevacizumab" (13 trials) and "Quality-of-Life Assessment" (13 trials). Other intervention names were less common.

The vast majority of trials in "Natalie Warren Bryant Cancer Center at Saint Francis" are 92 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Natalie Warren Bryant Cancer Center at Saint Francis". undefined are not yet recruiting, 5 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in Natalie Warren Bryant Cancer Center at Saint Francis, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Natalie Warren Bryant Cancer Center at Saint Francis, 6 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".